November 27, 2002, Updated September 19, 2012
Israel’s Keryx Biopharmaceuticals is shepherding a drug through the final stages of U.S. clinical trials that gives hope to the three to four million U.S. diabetes sufferers who experience kidney failure along with their diabetes.
Israel’s Keryx Biopharmaceuticals is shepherding a drug through the final stages of U.S. clinical trials that gives hope to the three to four million U.S. diabetes sufferers who experience kidney failure along with their diabetes.
Fighting for Israel's truth
We cover what makes life in Israel so special — it's people. A non-profit organization, ISRAEL21c's team of journalists are committed to telling stories that humanize Israelis and show their positive impact on our world. You can bring these stories to life by making a donation of $6/month.
